202 related articles for article (PubMed ID: 17243373)
1. Relationship between the chemical structures and biological activities (toxicity, mutagenic and antitumor) in newly synthesized derivatives of pyrazolo pyrimidines.
Nersesyan A; Muradyan R; Arsenyan F; Danagulyan G
Tsitol Genet; 2006; 40(6):28-32. PubMed ID: 17243373
[TBL] [Abstract][Full Text] [Related]
2. The influence of three newly synthesized pyrimidine-containing compounds on micronucleus induction and tumor growth.
Nersesyan A; Muradyan R; Arsenyan F
J BUON; 2007; 12(4):521-7. PubMed ID: 18067211
[TBL] [Abstract][Full Text] [Related]
3. Micronucleus-inducing and antitumor activity of three newly synthesized bridged nitrogen atom-containing pyrimidines.
Nersesyan A; Muradyan R; Arsenyan F; Danagulyan G
J BUON; 2006; 11(3):329-34. PubMed ID: 17309158
[TBL] [Abstract][Full Text] [Related]
4. [Micronuclear and antitumor activities of two newly synthesized pyrimidine derivatives].
Nersesian AK; Muradian RE; Arsenian FG
Tsitologiia; 2008; 50(1):79-82. PubMed ID: 18409373
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, anticancer and radioprotective activities of some new pyrazolo[3,4-d]pyrimidines containing amino acid moieties.
Ghorab MM; Ragab FA; Noaman E; Heiba HI; Aboulmagd SA
Arzneimittelforschung; 2009; 59(2):96-103. PubMed ID: 19338140
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and anti-tumor activities of some new pyridines and pyrazolo[1,5-a]pyrimidines.
Ahmed OM; Mohamed MA; Ahmed RR; Ahmed SA
Eur J Med Chem; 2009 Sep; 44(9):3519-23. PubMed ID: 19398146
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and anti-tumor activities of novel pyrazolo[1,5-a]pyrimidines.
Li J; Zhao YF; Zhao XL; Yuan XY; Gong P
Arch Pharm (Weinheim); 2006 Nov; 339(11):593-7. PubMed ID: 17036367
[TBL] [Abstract][Full Text] [Related]
8. Genotoxic activity of newly synthesized derivatives of cyano-pyridone in murine cells in vivo and in vitro.
Nersesyan K; Melikyan GS; Stopper H
Tsitol Genet; 2004; 38(4):44-8. PubMed ID: 15715164
[TBL] [Abstract][Full Text] [Related]
9. Cancerostatica. I. synthesis of some pyrazolo[1,5-a]pyrimidine and pyrazolo [3,4-b] pyridine derivatives.
Nantka-Namirski P; Kaczmarek L
Pol J Pharmacol Pharm; 1978; 30(4):563-8. PubMed ID: 740557
[TBL] [Abstract][Full Text] [Related]
10. Novel 6-N-arylcarboxamidopyrazolo[4,3-d]pyrimidin-7-one derivatives as potential anti-cancer agents.
Devegowda VN; Kim JH; Han KC; Yang EG; Choo H; Pae AN; Nam G; Choi KI
Bioorg Med Chem Lett; 2010 Mar; 20(5):1630-3. PubMed ID: 20138760
[TBL] [Abstract][Full Text] [Related]
11. Pyrazolo[3,4-d]pyrimidines endowed with antiproliferative activity on ductal infiltrating carcinoma cells.
Carraro F; Pucci A; Naldini A; Schenone S; Bruno O; Ranise A; Bondavalli F; Brullo C; Fossa P; Menozzi G; Mosti L; Manetti F; Botta M
J Med Chem; 2004 Mar; 47(7):1595-8. PubMed ID: 15027847
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, antitumor evaluation, molecular modeling and quantitative structure-activity relationship (QSAR) of some novel arylazopyrazolodiazine and triazine analogs.
El-Shafei A; Fadda AA; Khalil AM; Ameen TA; Badria FA
Bioorg Med Chem; 2009 Jul; 17(14):5096-105. PubMed ID: 19527933
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and antitumor activity of duocarmycin derivatives: modification of segment-A of A-ring pyrrole compounds.
Amishiro N; Okamoto A; Murakata C; Tamaoki T; Okabe M; Saito H
J Med Chem; 1999 Jul; 42(15):2946-60. PubMed ID: 10425104
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological evaluation of pyrazolo[4,3-d]pyrimidine analogues.
Yuan L; Song C; Li C; Li Y; Dong L; Yin S
Eur J Med Chem; 2013 Sep; 67():152-7. PubMed ID: 23851116
[TBL] [Abstract][Full Text] [Related]
15. Design and synthesis of novel thiophenecarbohydrazide, thienopyrazole and thienopyrimidine derivatives as antioxidant and antitumor agents.
Abu-Hashem AA; El-Shehry MF; Badria FA
Acta Pharm; 2010 Sep; 60(3):311-23. PubMed ID: 21134865
[TBL] [Abstract][Full Text] [Related]
16. Structure-based optimization of pyrazolo[3,4-d]pyrimidines as Abl inhibitors and antiproliferative agents toward human leukemia cell lines.
Manetti F; Brullo C; Magnani M; Mosci F; Chelli B; Crespan E; Schenone S; Naldini A; Bruno O; Trincavelli ML; Maga G; Carraro F; Martini C; Bondavalli F; Botta M
J Med Chem; 2008 Mar; 51(5):1252-9. PubMed ID: 18257513
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, biological activity, and ADME properties of pyrazolo[3,4-d]pyrimidines active in hypoxic human leukemia cells: a lead optimization study.
Radi M; Dreassi E; Brullo C; Crespan E; Tintori C; Bernardo V; Valoti M; Zamperini C; Daigl H; Musumeci F; Carraro F; Naldini A; Filippi I; Maga G; Schenone S; Botta M
J Med Chem; 2011 Apr; 54(8):2610-26. PubMed ID: 21443205
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and antitumor properties of pyrazolo [3,4-D] pyrimidine derivatives.
Witkiewicz K; MachoĊ Z; Mordarski M; Wieczorek J
Pol J Pharmacol Pharm; 1987; 39(6):715-20. PubMed ID: 3503990
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and antitumor activity of new sulfonamide derivatives of thiadiazolo[3,2-a]pyrimidines.
El-Sayed NS; El-Bendary ER; El-Ashry SM; El-Kerdawy MM
Eur J Med Chem; 2011 Sep; 46(9):3714-20. PubMed ID: 21705114
[TBL] [Abstract][Full Text] [Related]
20. The cytotoxic activity of 1-acyl- and 1,2-diacyl-4,4-diethyl-3,5-pyrazolidinediones.
Hall IH; Izydore RA; Vital TS; Chen SY; Miller MC; Bernal-Ramirez JA; Okwisa WA; Rajendran KG
Anticancer Res; 1995; 15(1):199-204. PubMed ID: 7733634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
